Microbiome and skin diseases : Current Opinion in Allergy and Clinical Immunology

Secondary Logo

Journal Logo

SKIN ALLERGY: Edited by Torsten Zuberbier and Thomas Werfel

Microbiome and skin diseases

Zeeuwen, Patrick L.J.M.; Kleerebezem, Michiel; Timmerman, Harro M.; Schalkwijk, Joost

Author Information
Current Opinion in Allergy and Clinical Immunology 13(5):p 514-520, October 2013. | DOI: 10.1097/ACI.0b013e328364ebeb


Purpose of review 

This article reviews recent findings on the skin microbiome. It provides an update on the current understanding of the role of microbiota in healthy skin and in inflammatory and allergic skin diseases.

Recent findings 

Advances in computing and high-throughput sequencing technology have enabled in-depth analysis of microbiota composition and functionality of human skin. Most data generated to date are related to the skin microbiome of healthy volunteers, but recent studies have also addressed the dynamics of the microbiome in diseased and injured skin. Currently, reports are emerging that evaluate the strategies to manipulate the skin microbiome, intending to modulate diseases and/or their symptoms.


The microbiome of normal human skin was found to have a high diversity and high interpersonal variation. Microbiota compositions of diseased lesional skin (in atopic dermatitis and psoriasis) showed distinct differences compared with healthy skin. The function of microbial colonization in establishing immune system homeostasis has been reported, whereas host–microbe interactions and genetically determined variation of stratum corneum properties might be linked to skin dysbiosis. Both are relevant for cutaneous disorders with aberrant immune responses and/or disturbed skin barrier function. Modulation of skin microbiota composition to restore host–microbiota homeostasis could be future strategies to treat or prevent disease.

Copyright © 2013 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid